Screener
Edwards Lifesciences EW Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on trailing twelve months.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's return on invested capital?
- Edwards Lifesciences (EW) reported return on invested capital of 13.7% in Q1 2026.
- How has Edwards Lifesciences's return on invested capital changed year-over-year?
- Edwards Lifesciences's return on invested capital decreased by 23.0% year-over-year, from 17.8% to 13.7%.
- What is the long-term trend for Edwards Lifesciences's return on invested capital?
- Over 5 years (2020 to 2025), Edwards Lifesciences's return on invested capital has grown at a -8.6% compound annual growth rate (CAGR), from 20.9% to 13.3%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Edwards Lifesciences's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude